<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00480961</url>
  </required_header>
  <id_info>
    <org_study_id>IRRB/00/2006</org_study_id>
    <nct_id>NCT00480961</nct_id>
  </id_info>
  <brief_title>Congestive Heart Failure Surgical Treatmment With Autologous Stem Cell Therapy</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Mediterranean Institute for Transplantation and Advanced Specialized Therapies</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Mediterranean Institute for Transplantation and Advanced Specialized Therapies</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research study was designed to test the safety and effectiveness of autologous stem cell
      graft in the myocardium of patients with refractory Congestive Heart Failure (CHF) with
      ischemic etiology. Cellular implantation will take place during off-pump revascularization
      surgery or during an ad hoc procedure using a mini-thoracotomy access.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary target: determine the safety of introducing CD 34+ autologous progenitor cells
      (centrally grafted or mobilized in peripheral blood) in the myocardium of ischemic cardiac
      disease patients. Secondary target: determine clinical effects of grafted cells on remodeling
      pathology.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2007</start_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary target: determine the safety of introducing CD 34+ autologous progenitor cells (centrally grafted or mobilized in peripheral blood) in the myocardium of ischemic cardiac disease patients.</measure>
    <time_frame>1 YEAR</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary target: determine clinical effects of grafted cells on remodeling pathology.</measure>
    <time_frame>1 YEAR</time_frame>
  </secondary_outcome>
  <condition>Congestive Heart Failure</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>intramiocardiac autograft of autologous stem cells</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria

          -  Age &gt;18 y/o

          -  CHF with EF &gt; 35%

          -  Bilirubinemia, serum transaminase&gt; 2.5 times normal max level

          -  Creatininemia &gt; 2.5 times max level

          -  NYHA Class &gt; 3

          -  Negative pregnancy test (for women in fertile age)

        Exclusion criteria

          -  Impossibility to harvest the bone marrow

          -  Pregnancy or breast-feeding

          -  History of malignant neoplasia in the 5-year period before the study (save for in-situ
             carcinoma of the cervix treated successfully and skin tumors â€“ not melanomas)

          -  Incapability or unwillingness to comply with the envisaged treatment protocol,
             follow-up, or tests.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>CESARE SCARDULLA, md</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Mediterranean Institute for Transplantation and Advanced Specialized Therapies</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>cesare scardulla, MD</last_name>
    <phone>0912192284</phone>
    <email>cscardulla@ISMETT.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ismett</name>
      <address>
        <city>Palermo</city>
        <state>PA</state>
        <zip>90127</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>CESARE SCARDULLA, md</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>May 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 31, 2007</study_first_submitted>
  <study_first_submitted_qc>May 31, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 1, 2007</study_first_posted>
  <last_update_submitted>May 31, 2007</last_update_submitted>
  <last_update_submitted_qc>May 31, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 1, 2007</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

